Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cooper Companies (COO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 11,551,711
  • Shares Outstanding, K 48,950
  • Annual Sales, $ 1,967 M
  • Annual Income, $ 273,920 K
  • 36-Month Beta 0.59
  • Price/Sales 6.20
  • Price/Cash Flow 19.84
  • Price/Book 3.93

Price Performance

See More
Period Period Low Period High Performance
1-Month
232.80 +1.42%
on 09/20/17
254.48 -7.22%
on 09/12/17
-8.94 (-3.65%)
since 08/18/17
3-Month
232.80 +1.42%
on 09/20/17
256.39 -7.91%
on 07/19/17
-6.68 (-2.75%)
since 06/20/17
52-Week
158.73 +48.75%
on 12/01/16
256.39 -7.91%
on 07/19/17
+49.70 (+26.66%)
since 09/20/16

Most Recent Stories

More News
4 Momentum Stocks to Pick Despite MedTech Policy Debacle

Investors might pay heed to Zacks counsel and hitch the momentum ride to tide over the Obamacare debacle.

MEDP : 31.02 (-0.58%)
COO : 236.11 (+0.05%)
ICLR : 110.61 (-1.65%)
MZOR : 49.96 (+6.93%)
Teva's Leukemia Drug sNDA Granted Priority Review by the FDA

Teva Pharmaceutical's (TEVA) sNDA for label expansion of Trisenox as first-line treatment of acute promyelocytic leukemia has been accepted by the FDA under priority review.

COO : 236.11 (+0.05%)
HLUYY : 58.8300 (+1.19%)
TEVA : 17.11 (-0.47%)
ADRO : 11.00 (unch)
Dental Faces Regulatory Challenges: Only 5 Stocks to Pick

Owing to the adversities in the medical universe, market watchers have adopted a bearish stance toward the dental space. These are the only five dental stocks that are expected to beat the ongoing MedTech...

VWR : 33.18 (+0.27%)
AAPL : 156.07 (-1.68%)
MMSI : 40.80 (-0.61%)
COO : 236.11 (+0.05%)
SAUHF : 647.4400 (+0.29%)
HYH : 46.15 (+0.50%)
Cooper Companies Buys Teva's PARAGARD Intrauterine Platform

Cooper Companies (COO) latest development is expected to fortify its foothold in the contraceptive device market. Margins are likely to improve within one year of the deal closure.

EW : 111.72 (+0.40%)
COO : 236.11 (+0.05%)
IDXX : 158.48 (-1.28%)
TEVA : 17.11 (-0.47%)
The Cooper Companies Announces Definitive Agreement to Acquire PARAGARD(R) IUD From Teva

The Cooper Companies, Inc. (NYSE:COO) today announced it has entered into a definitive asset purchase agreement with Teva Pharmaceutical Industries Ltd. to acquire the global rights and business of its...

COO : 236.11 (+0.05%)
TEVA : 17.11 (-0.47%)
Top Ranked Momentum Stocks to Buy for September 8th

Top Ranked Momentum Stocks to Buy for September 8th

BDC : 79.28 (-0.19%)
COO : 236.11 (+0.05%)
ITRN : 36.05 (-0.96%)
BLD : 60.70 (-0.23%)
Cooper to Benefit From Specialty Lenses Prospects Amid Woes

The Cooper Companies' (COO) strong sales growth will continue to be aided by a leading position in the market of specialty lenses.

EW : 111.72 (+0.40%)
COO : 236.11 (+0.05%)
LNTH : 17.45 (+1.16%)
IDXX : 158.48 (-1.28%)
Corporate News Blog - Teleflex to Acquire NeoTract

Research Desk Line-up: Cooper Cos. Post Earnings Coverage

COO : 236.11 (+0.05%)
TFX : 236.86 (-1.21%)
4 Large-Cap Medical Device Stocks to Buy Amid Political Woes

Investors facing political doldrums can safely place their bets on the Medical Device space on four large-cap medical device stocks that are poised for impressive returns over the next five years.

EW : 111.72 (+0.40%)
COO : 236.11 (+0.05%)
ICLR : 110.61 (-1.65%)
IDXX : 158.48 (-1.28%)
The Cooper Companies (COO) Beats Earnings Estimates in Q3

The Cooper Companies (COO) provided strong guidance for fiscal 2017. However, the soft outlook for CooperSurgical indicates looming concerns.

EW : 111.72 (+0.40%)
COO : 236.11 (+0.05%)
CGNT : 2.57 (-8.39%)
IDXX : 158.48 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

The Cooper Companies, Inc., through its principal subsidiaries, develops, manufactures and markets healthcare products. CooperVision markets a range of contact lenses to correct visual defects, specializing in toric lenses that correct astigmatism. The company also markets conventional toric and spherical...

See More

Support & Resistance

2nd Resistance Point 242.70
1st Resistance Point 239.41
Last Price 236.11
1st Support Level 232.81
2nd Support Level 229.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.